Vitrous Analysis in Proliferative Diabetic Retinopathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by St. Erik Eye Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Anders Kvanta, St. Erik Eye Hospital
ClinicalTrials.gov Identifier:
NCT01478763
First received: November 21, 2011
Last updated: June 5, 2012
Last verified: June 2012
  Purpose

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy


Condition
Proliferative Diabetic Retinopathy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Resource links provided by NLM:


Further study details as provided by St. Erik Eye Hospital:

Biospecimen Retention:   Samples With DNA

Vitreous samples


Estimated Enrollment: 200
Study Start Date: January 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Detailed Description:

To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.

  Eligibility

Ages Eligible for Study:   12 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Criteria

Inclusion Criteria:

  • proliferative diabetic retinopathy with vitreous hemorrhage

Exclusion Criteria:

  • vitreous hemorrhage of other cause than proliferative diabetic retinopathy
  • previous vitrectomy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01478763

Locations
Sweden
St. Erik Eye Hospital Recruiting
Stockholm, NonUS, Sweden, 11282
Contact: Anders Kvanta, PhD    004686723000    anders.kvanta@sankterik.se   
Sponsors and Collaborators
Anders Kvanta
Investigators
Principal Investigator: Anders Kvanta, PhD St. Erik Eye Hospital
  More Information

No publications provided

Responsible Party: Anders Kvanta, Professor, St. Erik Eye Hospital
ClinicalTrials.gov Identifier: NCT01478763     History of Changes
Other Study ID Numbers: Vitreous1
Study First Received: November 21, 2011
Last Updated: June 5, 2012
Health Authority: Sweden: Regional Ethical Review Board

Keywords provided by St. Erik Eye Hospital:
PDRP
vitreous
protein
vitrectomy

Additional relevant MeSH terms:
Diabetic Retinopathy
Retinal Diseases
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on July 26, 2014